Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal

Nigel Armstrong; Manuela Joore; Thea van Asselt; Kate Misso; Nathan Manning; Florian Tomini; Jos Kleijnen; Rob Riemsma

doi:10.1007/s40273-013-0049-2

Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal

Nigel Armstrong^*, Manuela Joore, Thea van Asselt, Kate Misso, Nathan Manning, Florian Tomini, Jos Kleijnen, Rob Riemsma

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	415-425
Journal	Pharmacoeconomics
Volume	31
Issue number	5
DOIs	https://doi.org/10.1007/s40273-013-0049-2
Publication status	Published - 2013

Access to Document

10.1007/s40273-013-0049-2

Cite this

@article{7ca3b0fb5a4643f08a1c108f859e980e,

title = "Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal",

author = "Nigel Armstrong and Manuela Joore and {van Asselt}, Thea and Kate Misso and Nathan Manning and Florian Tomini and Jos Kleijnen and Rob Riemsma",

year = "2013",

doi = "10.1007/s40273-013-0049-2",

language = "English",

volume = "31",

pages = "415--425",

journal = "Pharmacoeconomics",

issn = "1170-7690",

publisher = "Adis International Ltd",

number = "5",

}

TY - JOUR

T1 - Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal

AU - Armstrong, Nigel

AU - Joore, Manuela

AU - van Asselt, Thea

AU - Misso, Kate

AU - Manning, Nathan

AU - Tomini, Florian

AU - Kleijnen, Jos

AU - Riemsma, Rob

PY - 2013

Y1 - 2013

U2 - 10.1007/s40273-013-0049-2

DO - 10.1007/s40273-013-0049-2

M3 - Article

C2 - 23580355

VL - 31

SP - 415

EP - 425

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 5

ER -